rhenium-186 hedp has been researched along with Cancer Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloemendal, HJ; de Klerk, JM; Hoekstra, OS; Hooft, L; Jong, JM; Oprea-Lager, DE; van den Eertwegh, AJ; Verheul, HM | 1 |
| Bloemendal, HJ; de Klerk, JM; Hendrikse, NH; Kooistra, A; Lange, R; Overbeek, F; Pasker-de Jong, PC; Rodenburg, CJ; Ter Heine, R; van den Berk, AM | 1 |
1 review(s) available for rhenium-186 hedp and Cancer Pain
| Article | Year |
|---|---|
Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
Topics: Antineoplastic Agents; Bone Neoplasms; Cancer Pain; Etidronic Acid; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic; Strontium; Strontium Radioisotopes | 2016 |
1 trial(s) available for rhenium-186 hedp and Cancer Pain
| Article | Year |
|---|---|
Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world study.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Cancer Pain; Comorbidity; Etidronic Acid; Female; Humans; Male; Netherlands; Organometallic Compounds; Palliative Care; Prevalence; Prostatic Neoplasms; Quality of Life; Radiopharmaceuticals; Risk Factors; Treatment Outcome | 2016 |